Company · CIK 0001610950 · SIC 8731 — Services-Commercial Physical & Biological Research
Syneos Health, Inc. · SYNH
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2017 SForm 4 → | Jan 4, 4:02 pm EST | Gregory S RushExecutive VP and CFO | 41,420 | $51.90 | $2,149,818 | 47,209 | −46.7% | plan? |
| Jan 3, 2017 MForm 4 → | Jan 4, 4:02 pm EST | Gregory S RushExecutive VP and CFO | 41,420 | $10.92 | $452,187 | 53,126 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 1, 5:37 pm EDT | Matthew E. MonaghanDirector | 1,223 | — | — | 1,223 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 1, 4:01 pm EDT | Kenneth F MeyersDirector | 1,223 | — | — | 1,223 | — | plan? |
| Sep 30, 2016 SForm 4 → | Oct 3, 6:57 am EDT | Gregory S RushExecutive VP and CFO | 35,503 | $44.70 | $1,586,913 | 47,209 | −42.9% | plan? |
| Sep 30, 2016 MForm 4 → | Oct 3, 6:57 am EDT | Gregory S RushExecutive VP and CFO | 35,503 | $10.06 | $357,160 | 82,712 | — | plan? |
| Sep 27, 2016 MForm 4 → | Sep 28, 4:08 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 36,688 | $14.83 | $544,119 | 77,863 | — | plan? |
| Sep 27, 2016 SForm 4 → | Sep 28, 4:08 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 53,970 | $44.30 | $2,391,062 | 58,927 | −47.8% | plan? |
| Sep 26, 2016 SForm 4 → | Sep 28, 6:07 am EDT | Robert W BreckonDirector | 12,197 | $44.16 | $538,624 | 3,364 | −78.4% | plan? |
| Sep 26, 2016 MForm 4 → | Sep 28, 6:07 am EDT | Robert W BreckonDirector | 7,600 | $8.45 | $64,220 | 15,561 | — | plan? |
| Sep 19, 2016 PForm 4 → | Sep 20, 4:01 pm EDT | David F BurgstahlerDirector, 10% Owner | 1,000 | $43.19 | $43,187 | 36,065 | +2.85% | plan? |
| Sep 15, 2016 AForm 4 → | Sep 16, 4:03 pm EDT | David F BurgstahlerDirector, 10% Owner | 1,729 | — | — | 35,065 | — | plan? |
| Sep 15, 2016 AForm 4 → | Sep 16, 8:05 am EDT | Gregory S RushExecutive VP and CFO | 29,110 | — | — | 47,209 | — | plan? |
| Sep 15, 2016 AForm 4 → | Sep 16, 8:01 am EDT | Michael GibertiniPresident Clinical Development | 29,110 | — | — | 47,639 | — | plan? |
| Sep 14, 2016 SForm 4 → | Sep 16, 8:03 am EDT | Christopher L GaenzleCAO, GC & Sec | 4,734 | $43.14 | $204,234 | 14,518 | −24.6% | plan? |
| Sep 14, 2016 AMForm 4 → | Sep 16, 8:03 am EDT | Christopher L GaenzleCAO, GC & Sec | 31,516 | $10.06 | $47,624 | 41,300 | — | plan? |
| Aug 24, 2016 JForm 4 → | Sep 1, 4:01 pm EDT | David F BurgstahlerDirector | 36,984 | — | — | 3,648 | — | plan? late |
| Aug 24, 2016 JForm 4 → | Aug 31, 4:03 pm EDT | Charles C Harwood Jr.Director | 8,753 | — | — | 26,294 | — | plan? late |
| Aug 17, 2016 SForm 4 → | Aug 18, 4:37 pm EDT | Alistair MacdonaldChief Operating Officer | 8,828 | $43.80 | $386,666 | 54,229 | −14.0% | plan? |
| Aug 17, 2016 MForm 4 → | Aug 18, 4:37 pm EDT | Alistair MacdonaldChief Operating Officer | 8,828 | $10.57 | $93,312 | 63,057 | — | plan? |
| Aug 4, 2016 SForm 4 → | Aug 5, 3:28 pm EDT | Teachers Pension Plan Board Ontario +1Director, 10% Owner | 2,445,591 | $42.06 | $102,861,557 | 3,944,174 | −38.3% | plan? |
| Aug 4, 2016 SForm 4 → | Aug 5, 3:25 pm EDT | Avista Capital Partners II GP, LLC +510% Owner | 2,554,409 | $42.06 | $107,438,443 | 4,119,676 | −38.3% | plan? |
| Aug 2, 2016 SForm 4 → | Aug 3, 4:04 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 31,279 | $43.00 | $1,344,997 | 76,209 | −29.1% | plan? |
| Aug 2, 2016 MForm 4 → | Aug 3, 4:04 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 31,279 | $10.57 | $330,619 | 107,488 | — | plan? |
| Aug 1, 2016 AForm 4 → | Aug 2, 4:04 pm EDT | Alistair MacdonaldChief Operating Officer | 35,553 | — | — | 54,229 | — | plan? |
| Aug 1, 2016 SForm 4 → | Aug 2, 4:01 pm EDT | Robert W BreckonDirector | 108 | $42.00 | $4,536 | 7,961 | −1.34% | plan? |
| Jul 28, 2016 SForm 4 → | Jul 29, 9:08 am EDT | Gregory S RushExecutive VP and CFO | 4,066 | $45.23 | $183,889 | 18,099 | −18.3% | plan? |
| Jul 28, 2016 MForm 4 → | Jul 29, 9:08 am EDT | Gregory S RushExecutive VP and CFO | 4,066 | $40.12 | $163,128 | 22,165 | — | plan? |
| Jul 20, 2016 SForm 4 → | Jul 21, 4:43 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 100,593 | $43.00 | $4,325,499 | 76,209 | −56.9% | plan? |
| Jul 20, 2016 MForm 4 → | Jul 21, 4:43 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 100,593 | $10.57 | $1,063,268 | 147,216 | — | plan? |
| Jul 15, 2016 SForm 4 → | Jul 18, 8:40 am EDT | Gregory S RushExecutive VP and CFO | 5,917 | $41.50 | $245,538 | 18,099 | −24.6% | plan? |
| Jul 15, 2016 MForm 4 → | Jul 18, 8:40 am EDT | Gregory S RushExecutive VP and CFO | 5,917 | $16.06 | $95,027 | 24,016 | — | plan? |
| Jul 11, 2016 SForm 4 → | Jul 12, 4:01 pm EDT | Alistair MacdonaldChief Operating Officer | 9,468 | $40.19 | $380,500 | 18,676 | −33.6% | plan? |
| Jul 11, 2016 MForm 4 → | Jul 12, 4:01 pm EDT | Alistair MacdonaldChief Operating Officer | 9,468 | $16.06 | $152,056 | 28,144 | — | plan? |
| Jul 11, 2016 SForm 4 → | Jul 12, 4:00 pm EDT | Christopher L GaenzleCAO, GC & Sec | 21,918 | $40.20 | $881,077 | 14,518 | −60.2% | plan? |
| Jul 11, 2016 MForm 4 → | Jul 12, 4:00 pm EDT | Christopher L GaenzleCAO, GC & Sec | 20,701 | $15.29 | $316,504 | 18,641 | — | plan? |
| Jul 1, 2016 SForm 4 → | Jul 5, 4:01 pm EDT | Robert W BreckonDirector | 421 | $37.97 | $15,985 | 8,069 | −4.96% | plan? |
| Jul 1, 2016 SForm 4 → | Jul 5, 8:17 am EDT | Gregory S RushExecutive VP and CFO | 1,358 | $37.97 | $51,563 | 18,099 | −6.98% | plan? |
| Jun 30, 2016 FForm 4 → | Jul 5, 8:17 am EDT | Gregory S RushExecutive VP and CFO | 675 | $38.13 | $25,738 | 19,457 | — | plan? |
| Jun 30, 2016 FForm 4 → | Jul 1, 4:10 pm EDT | Christopher L GaenzleCAO, GC & Sec | 606 | $38.13 | $23,107 | 15,735 | — | plan? |
| Jun 30, 2016 FForm 4 → | Jul 1, 4:09 pm EDT | Michael GibertiniPresident Clinical Development | 883 | $38.13 | $33,669 | 18,529 | — | plan? |
| Jun 30, 2016 FForm 4 → | Jul 1, 4:07 pm EDT | Alistair MacdonaldChief Operating Officer | 1,023 | $38.13 | $39,007 | 18,676 | — | plan? |
| Jun 30, 2016 FForm 4 → | Jul 1, 4:05 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 3,017 | $38.13 | $115,038 | 76,209 | — | plan? |
| Jun 14, 2016 SForm 4 → | Jun 16, 9:03 am EDT | Christopher L GaenzleCAO, GC & Sec | 7,702 | $40.14 | $309,140 | 16,341 | −32.0% | plan? |
| Jun 14, 2016 MForm 4 → | Jun 16, 9:03 am EDT | Christopher L GaenzleCAO, GC & Sec | 7,702 | $14.76 | $113,658 | 20,269 | — | plan? |
| Jun 6, 2016 SForm 4 → | Jun 7, 4:04 pm EDT | Michael GibertiniPresident Clinical Development | 213,966 | $43.11 | $9,223,171 | 19,412 | −91.7% | plan? |
| Jun 6, 2016 MForm 4 → | Jun 7, 4:04 pm EDT | Michael GibertiniPresident Clinical Development | 186,096 | $9.34 | $1,738,615 | 65,034 | — | plan? |
| Jun 1, 2016 SForm 4 → | Jun 3, 4:07 pm EDT | Robert W BreckonDirector | 11,691 | $43.53 | $508,938 | 8,490 | −57.9% | plan? |
| Jun 1, 2016 MForm 4 → | Jun 3, 4:07 pm EDT | Robert W BreckonDirector | 9,518 | $8.45 | $80,427 | 11,134 | — | plan? |
| May 24, 2016 AForm 4 → | May 25, 4:06 pm EDT | James T. OgleDirector | 2,231 | — | — | 180,617 | — | plan? |
| May 24, 2016 AForm 4 → | May 25, 4:04 pm EDT | David Y NortonDirector | 2,231 | — | — | 4,295 | — | plan? |
| May 24, 2016 AForm 4 → | May 25, 4:03 pm EDT | Richard N KenderDirector | 2,231 | — | — | 4,455 | — | plan? |
| May 24, 2016 AForm 4 → | May 25, 4:01 pm EDT | Charles C Harwood Jr.Director | 2,231 | — | — | 17,541 | — | plan? |
| May 24, 2016 AForm 4 → | May 25, 4:00 pm EDT | Robert W BreckonDirector | 2,231 | — | — | 10,663 | — | plan? |
| May 6, 2016 SForm 4 → | May 9, 5:03 pm EDT | Teachers Pension Plan Board Ontario +1Director, 10% Owner | 3,912,946 | $45.12 | $176,552,124 | 6,389,765 | −38.0% | plan? |
| May 6, 2016 SForm 4 → | May 9, 4:22 pm EDT | Avista Capital Partners II GP, LLC +510% Owner | 4,087,054 | $45.12 | $184,407,876 | 6,674,085 | −38.0% | plan? |
| Apr 18, 2016 SForm 4 → | Apr 19, 4:01 pm EDT | James T. OgleDirector | 114,806 | $50.00 | $5,740,300 | 178,386 | −39.2% | plan? |
| Apr 18, 2016 MForm 4 → | Apr 19, 4:01 pm EDT | James T. OgleDirector | 114,806 | $8.45 | $970,111 | 293,192 | — | plan? |
| Apr 12, 2016 SForm 4 → | Apr 14, 8:26 am EDT | D. Jamie MacdonaldChief Executive Officer, Director | 94,675 | $48.00 | $4,544,400 | 79,226 | −54.4% | plan? |
| Apr 12, 2016 MForm 4 → | Apr 14, 8:26 am EDT | D. Jamie MacdonaldChief Executive Officer, Director | 94,675 | $10.57 | $1,000,715 | 114,729 | — | plan? |
| Apr 1, 2016 SForm 4 → | Apr 4, 6:29 pm EDT | Michael GibertiniPresident Clinical Development | 9,000 | $40.78 | $367,038 | 47,282 | −16.0% | plan? |
| Apr 1, 2016 MForm 4 → | Apr 4, 6:29 pm EDT | Michael GibertiniPresident Clinical Development | 9,000 | $8.45 | $76,050 | 56,282 | — | plan? |
| Mar 1, 2016 SForm 4 → | Mar 2, 4:06 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | $39.85 | $358,677 | 47,282 | −16.0% | plan? |
| Mar 1, 2016 MForm 4 → | Mar 2, 4:06 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | $8.45 | $76,050 | 56,282 | — | plan? |
| Feb 4, 2016 MForm 4 → | Feb 5, 4:18 pm EST | Robert W BreckonDirector | 2,787 | $8.45 | $23,550 | 11,219 | — | plan? |
| Feb 4, 2016 SForm 4 → | Feb 5, 4:18 pm EST | Robert W BreckonDirector | 3,882 | $40.03 | $155,381 | 8,432 | −31.5% | plan? |
| Feb 1, 2016 SForm 4 → | Feb 2, 4:02 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | $40.57 | $365,152 | 47,282 | −16.0% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 2, 4:02 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | $8.45 | $76,050 | 56,282 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 2, 4:00 pm EST | Gregory S RushExecutive VP and CFO | 17,752 | $40.27 | $714,861 | 20,132 | −46.9% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 2, 4:00 pm EST | Gregory S RushExecutive VP and CFO | 17,752 | $16.06 | $285,097 | 37,884 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:09 pm EST | Michael GibertiniPresident Clinical Development | 11,000 | — | — | 47,282 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:08 pm EST | Alistair MacdonaldChief Operating Officer | 11,000 | — | — | 19,699 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:06 pm EST | D. Jamie MacdonaldChief Executive Officer, Director | 40,000 | — | — | 79,226 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:05 pm EST | Christopher L GaenzleCAO, GC & Sec | 9,050 | — | — | 16,341 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:04 pm EST | Gregory S RushExecutive VP and CFO | 12,000 | — | — | 20,132 | — | plan? |
| Jan 4, 2016 SForm 4 → | Jan 6, 7:35 am EST | Michael GibertiniPresident Clinical Development | 9,000 | $46.83 | $421,493 | 36,282 | −19.9% | plan? |
| Jan 4, 2016 MForm 4 → | Jan 6, 7:35 am EST | Michael GibertiniPresident Clinical Development | 9,000 | $8.45 | $76,050 | 45,282 | — | plan? |
| Dec 31, 2015 SForm 4 → | Jan 4, 2016, 4:03 pm EST | Gregory S RushExecutive VP and CFO | 35,503 | $48.17 | $1,710,210 | 8,132 | −81.4% | plan? |
| Dec 31, 2015 MForm 4 → | Jan 4, 2016, 4:03 pm EST | Gregory S RushExecutive VP and CFO | 35,503 | $10.06 | $357,160 | 43,635 | — | plan? |
| Dec 31, 2015 SForm 4 → | Jan 4, 2016, 4:02 pm EST | Christopher L GaenzleCAO, GC & Sec | 9,468 | $48.18 | $456,207 | 7,291 | −56.5% | plan? |
| Dec 31, 2015 MForm 4 → | Jan 4, 2016, 4:02 pm EST | Christopher L GaenzleCAO, GC & Sec | 9,468 | $10.32 | $97,662 | 12,025 | — | plan? |
| Dec 31, 2015 MForm 4 → | Jan 4, 2016, 4:00 pm EST | Alistair MacdonaldChief Operating Officer | 112,617 | $11.37 | $1,280,069 | 37,103 | — | plan? |
| Dec 31, 2015 SForm 4 → | Jan 4, 2016, 4:00 pm EST | Alistair MacdonaldChief Operating Officer | 159,599 | $47.46 | $7,574,735 | 8,699 | −94.8% | plan? |
| Dec 29, 2015 SForm 4 → | Dec 31, 7:47 am EST | James T. OgleDirector | 9,717 | $50.06 | $486,452 | 183,386 | −5.03% | plan? |
| Dec 29, 2015 MForm 4 → | Dec 31, 7:47 am EST | James T. OgleDirector | 9,717 | $8.45 | $82,109 | 193,103 | — | plan? |
| Dec 7, 2015 SForm 4 → | Dec 9, 4:02 pm EST | Christopher L GaenzleCAO, GC & Sec | 25,185 | $41.78 | $1,052,338 | 7,291 | −77.5% | plan? |
| Dec 7, 2015 MForm 4 → | Dec 9, 4:02 pm EST | Christopher L GaenzleCAO, GC & Sec | 25,185 | $10.34 | $260,497 | 32,476 | — | plan? |
| Dec 7, 2015 SForm 4 → | Dec 9, 4:00 pm EST | Gregory S RushExecutive VP and CFO | 81,035 | $45.13 | $3,656,981 | 8,132 | −90.9% | plan? |
| Dec 7, 2015 MForm 4 → | Dec 9, 4:00 pm EST | Gregory S RushExecutive VP and CFO | 81,035 | $10.06 | $815,212 | 89,167 | — | plan? |
| Dec 7, 2015 SForm 4 → | Dec 9, 10:38 am EST | Alistair MacdonaldChief Operating Officer | 42,959 | $44.63 | $1,917,397 | 55,681 | −43.6% | plan? |
| Dec 7, 2015 MForm 4 → | Dec 9, 10:38 am EST | Alistair MacdonaldChief Operating Officer | 42,959 | $8.45 | $363,004 | 98,640 | — | plan? |
| Dec 7, 2015 SForm 4 → | Dec 8, 7:22 pm EST | Teachers Pension Plan Board Ontario +1Director, 10% Owner | 4,402,063 | $45.00 | $198,092,835 | 10,302,711 | −29.9% | plan? |
| Dec 7, 2015 SForm 4 → | Dec 8, 5:14 pm EST | Avista Capital Partners II GP, LLC +510% Owner | 4,597,937 | $45.00 | $206,907,165 | 10,761,139 | −29.9% | plan? |
| Dec 1, 2015 SForm 4 → | Dec 3, 8:44 am EST | Michael GibertiniPresident Clinical Development | 9,000 | $46.52 | $418,662 | 36,282 | −19.9% | plan? |
| Dec 1, 2015 MForm 4 → | Dec 3, 8:44 am EST | Michael GibertiniPresident Clinical Development | 9,000 | $8.45 | $76,050 | 45,282 | — | plan? |
| Nov 2, 2015 SForm 4 → | Nov 3, 4:01 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | $41.70 | $375,300 | 36,282 | −19.9% | plan? |
| Nov 2, 2015 MForm 4 → | Nov 3, 4:01 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | $8.45 | $76,050 | 45,282 | — | plan? |
| Sep 28, 2015 SForm 4 → | Sep 29, 4:02 pm EDT | Alistair MacdonaldChief Operating Officer | 44,522 | $39.93 | $1,777,629 | 55,681 | −44.4% | plan? |
| Sep 28, 2015 MForm 4 → | Sep 29, 4:02 pm EDT | Alistair MacdonaldChief Operating Officer | 44,522 | $8.45 | $376,211 | 100,203 | — | plan? |
| Sep 14, 2015 SForm 4 → | Sep 16, 8:20 am EDT | Gregory S RushExecutive VP and CFO | 32,426 | $45.06 | $1,460,999 | 8,132 | −79.9% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2019 MForm 4 → | Feb 15, 7:34 am EST | Alistair MacdonaldChief Executive Officer, Director | 8,143 | — | — | 0 | — | |
| Feb 5, 2019 MForm 4 → | Feb 7, 8:29 am EST | Alistair MacdonaldChief Executive Officer, Director | 6,697 | — | — | 8,143 | — | |
| May 7, 2018 AForm 4 → | May 9, 6:59 am EDT | Jason M. MeggsChief Financial Officer | 12,950 | — | — | 12,950 | — | |
| Feb 15, 2018 AForm 4 → | Feb 20, 4:00 pm EST | Alistair MacdonaldChief Executive Officer, Director | 79,470 | — | — | 79,470 | — | |
| Sep 1, 2017 MForm 4 → | Sep 5, 8:38 pm EDT | Gregory S RushChief Financial Officer | 98,739 | — | — | 8,132 | — | |
| Sep 1, 2017 MForm 4 → | Sep 5, 4:02 pm EDT | Christopher L GaenzleCAO, GC & Sec | 42,601 | — | — | 0 | — | |
| Aug 30, 2017 MForm 4/A → | Sep 5, 8:30 pm EDT | Gregory S RushChief Financial Officer | 41,420 | — | — | 23,668 | — | |
| Aug 30, 2017 MForm 4 → | Sep 1, 7:10 pm EDT | Gregory S RushChief Financial Officer | 41,420 | — | — | 23,668 | — | amended |
| Aug 17, 2017 MForm 4 → | Aug 21, 7:39 am EDT | Alistair MacdonaldChief Executive Officer, Director | 8,828 | — | — | 8,828 | — | |
| Aug 10, 2017 AForm 4 → | Aug 14, 7:38 am EDT | Christopher L GaenzleCAO, GC & Sec | 11,475 | — | — | 11,475 | — | |
| Aug 10, 2017 AForm 4 → | Aug 14, 7:37 am EDT | Gregory S RushExecutive VP and CFO | 11,803 | — | — | 11,803 | — | |
| Aug 10, 2017 AForm 4 → | Aug 14, 7:36 am EDT | Michael Adam BellExec Chair & Pres, Comm Div, Director | 29,143 | — | — | 29,143 | — | |
| Aug 10, 2017 AForm 4 → | Aug 14, 7:34 am EDT | Alistair MacdonaldChief Executive Officer, Director | 36,429 | — | — | 36,429 | — | |
| Aug 1, 2017 MForm 4 → | Aug 3, 8:12 am EDT | Alistair MacdonaldChief Executive Officer, Director | 48,921 | — | — | 0 | — | |
| Aug 1, 2017 MForm 4 → | Aug 2, 4:15 pm EDT | Michael GibertiniOther | 32,351 | — | — | 0 | — | |
| Aug 1, 2017 MForm 4 → | Aug 2, 4:12 pm EDT | Christopher L GaenzleCAO, GC & Sec | 27,495 | — | — | 0 | — | |
| Aug 1, 2017 MForm 4 → | Aug 2, 4:11 pm EDT | Gregory S RushExecutive VP and CFO | 35,291 | — | — | 0 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 7:42 am EDT | Christopher L GaenzleCAO, GC & Sec | 5,917 | — | — | 23,668 | — | |
| Jun 30, 2017 MForm 4 → | Jul 5, 7:40 am EDT | Alistair MacdonaldChief Executive Officer, Director | 9,467 | — | — | 37,868 | — | |
| May 1, 2017 MForm 4 → | May 2, 4:01 pm EDT | Alistair MacdonaldChief Executive Officer, Director | 9,467 | — | — | 37,868 | — | |
| Apr 3, 2017 MForm 4 → | Apr 4, 4:00 pm EDT | Christopher L GaenzleCAO, GC & Sec | 4,733 | — | — | 4,733 | — | |
| Mar 3, 2017 MForm 4 → | Mar 6, 7:14 am EST | Alistair MacdonaldChief Executive Officer, Director | 8,828 | — | — | 17,656 | — | |
| Jan 27, 2017 AForm 4 → | Jan 30, 4:03 pm EST | Christopher L GaenzleCAO, GC & Sec | 13,920 | — | — | 13,920 | — | |
| Jan 27, 2017 AForm 4 → | Jan 30, 4:02 pm EST | Michael GibertiniChief Operating Officer | 15,851 | — | — | 15,851 | — | |
| Jan 27, 2017 AForm 4 → | Jan 30, 4:01 pm EST | Gregory S RushExecutive VP and CFO | 17,291 | — | — | 17,291 | — | |
| Jan 27, 2017 AForm 4 → | Jan 30, 4:00 pm EST | Alistair MacdonaldChief Executive Officer, Director | 32,421 | — | — | 32,421 | — | |
| Jan 19, 2017 MForm 4 → | Jan 23, 6:44 am EST | Gregory S RushExecutive VP and CFO | 1,334 | — | — | 3,999 | — | |
| Jan 5, 2017 MForm 4 → | Jan 6, 4:02 pm EST | Alistair MacdonaldChief Executive Officer, Director | 14,840 | — | — | 14,840 | — | |
| Jan 3, 2017 MForm 4 → | Jan 4, 4:03 pm EST | Christopher L GaenzleCAO, GC & Sec | 15,383 | — | — | 9,466 | — | |
| Jan 3, 2017 MForm 4 → | Jan 4, 4:02 pm EST | Gregory S RushExecutive VP and CFO | 41,420 | — | — | 29,585 | — | |
| Sep 30, 2016 MForm 4 → | Oct 3, 6:57 am EDT | Gregory S RushExecutive VP and CFO | 35,503 | — | — | 142,011 | — | |
| Sep 27, 2016 MForm 4 → | Sep 28, 4:08 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 36,688 | — | — | 75,738 | — | |
| Sep 26, 2016 MForm 4 → | Sep 28, 6:07 am EDT | Robert W BreckonDirector | 7,600 | — | — | 0 | — | |
| Sep 14, 2016 MForm 4 → | Sep 16, 8:03 am EDT | Christopher L GaenzleCAO, GC & Sec | 4,734 | — | — | 18,933 | — | |
| Aug 17, 2016 MForm 4 → | Aug 18, 4:37 pm EDT | Alistair MacdonaldChief Operating Officer | 8,828 | — | — | 26,484 | — | |
| Aug 2, 2016 MForm 4 → | Aug 3, 4:04 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 31,279 | — | — | 59,170 | — | |
| Aug 1, 2016 AForm 4 → | Aug 2, 4:04 pm EDT | Alistair MacdonaldChief Operating Officer | 35,553 | — | — | 35,553 | — | |
| Jul 28, 2016 MForm 4 → | Jul 29, 9:08 am EDT | Gregory S RushExecutive VP and CFO | 4,066 | — | — | 12,198 | — | |
| Jul 20, 2016 MForm 4 → | Jul 21, 4:43 pm EDT | D. Jamie MacdonaldChief Executive Officer, Director | 100,593 | — | — | 71,004 | — | |
| Jul 15, 2016 MForm 4 → | Jul 18, 8:40 am EDT | Gregory S RushExecutive VP and CFO | 5,917 | — | — | 35,502 | — | |
| Jul 11, 2016 MForm 4 → | Jul 12, 4:01 pm EDT | Alistair MacdonaldChief Operating Officer | 9,468 | — | — | 56,802 | — | |
| Jul 11, 2016 MForm 4 → | Jul 12, 4:00 pm EDT | Christopher L GaenzleCAO, GC & Sec | 20,701 | — | — | 14,199 | — | |
| Jun 14, 2016 MForm 4 → | Jun 16, 9:03 am EDT | Christopher L GaenzleCAO, GC & Sec | 7,702 | — | — | 53,297 | — | |
| Jun 6, 2016 MForm 4 → | Jun 7, 4:04 pm EDT | Michael GibertiniPresident Clinical Development | 186,096 | — | — | 41,419 | — | |
| Jun 1, 2016 MForm 4 → | Jun 3, 4:07 pm EDT | Robert W BreckonDirector | 9,518 | — | — | 7,600 | — | |
| Apr 18, 2016 MForm 4 → | Apr 19, 4:01 pm EDT | James T. OgleDirector | 114,806 | — | — | 0 | — | |
| Apr 12, 2016 MForm 4 → | Apr 14, 8:26 am EDT | D. Jamie MacdonaldChief Executive Officer, Director | 94,675 | — | — | 142,011 | — | |
| Apr 1, 2016 MForm 4 → | Apr 4, 6:29 pm EDT | Michael GibertiniPresident Clinical Development | 9,000 | — | — | 205,644 | — | |
| Mar 1, 2016 MForm 4 → | Mar 2, 4:06 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | — | — | 214,644 | — | |
| Feb 4, 2016 MForm 4 → | Feb 5, 4:18 pm EST | Robert W BreckonDirector | 2,787 | — | — | 9,047 | — | |
| Feb 1, 2016 MForm 4 → | Feb 2, 4:02 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | — | — | 223,644 | — | |
| Feb 1, 2016 MForm 4 → | Feb 2, 4:00 pm EST | Gregory S RushExecutive VP and CFO | 17,752 | — | — | 41,419 | — | |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:09 pm EST | Michael GibertiniPresident Clinical Development | 21,389 | — | — | 16,500 | — | |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:08 pm EST | Alistair MacdonaldChief Operating Officer | 21,389 | — | — | 16,500 | — | |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:06 pm EST | D. Jamie MacdonaldChief Executive Officer, Director | 77,778 | — | — | 60,000 | — | |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:05 pm EST | Christopher L GaenzleCAO, GC & Sec | 17,597 | — | — | 13,575 | — | |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:04 pm EST | Gregory S RushExecutive VP and CFO | 23,333 | — | — | 18,000 | — | |
| Jan 4, 2016 MForm 4 → | Jan 6, 7:35 am EST | Michael GibertiniPresident Clinical Development | 9,000 | — | — | 232,644 | — | |
| Dec 31, 2015 MForm 4 → | Jan 4, 2016, 4:03 pm EST | Gregory S RushExecutive VP and CFO | 35,503 | — | — | 177,514 | — | |
| Dec 31, 2015 MForm 4 → | Jan 4, 2016, 4:02 pm EST | Christopher L GaenzleCAO, GC & Sec | 9,468 | — | — | 18,933 | — | |
| Dec 31, 2015 MForm 4 → | Jan 4, 2016, 4:00 pm EST | Alistair MacdonaldChief Operating Officer | 112,617 | — | — | 66,270 | — | |
| Dec 29, 2015 MForm 4 → | Dec 31, 7:47 am EST | James T. OgleDirector | 9,717 | — | — | 114,806 | — | |
| Dec 7, 2015 MForm 4 → | Dec 9, 4:02 pm EST | Christopher L GaenzleCAO, GC & Sec | 25,185 | — | — | 28,401 | — | |
| Dec 7, 2015 MForm 4 → | Dec 9, 4:00 pm EST | Gregory S RushExecutive VP and CFO | 81,035 | — | — | 213,017 | — | |
| Dec 7, 2015 MForm 4 → | Dec 9, 10:38 am EST | Alistair MacdonaldChief Operating Officer | 42,959 | — | — | 60,921 | — | |
| Dec 1, 2015 MForm 4 → | Dec 3, 8:44 am EST | Michael GibertiniPresident Clinical Development | 9,000 | — | — | 241,644 | — | |
| Nov 2, 2015 MForm 4 → | Nov 3, 4:01 pm EST | Michael GibertiniPresident Clinical Development | 9,000 | — | — | 250,644 | — | |
| Sep 28, 2015 MForm 4 → | Sep 29, 4:02 pm EDT | Alistair MacdonaldChief Operating Officer | 44,522 | — | — | 103,880 | — | |
| Sep 14, 2015 MForm 4 → | Sep 16, 8:20 am EDT | Gregory S RushExecutive VP and CFO | 32,426 | — | — | 294,052 | — | |
| Aug 31, 2015 MForm 4 → | Sep 1, 4:06 pm EDT | Christopher L GaenzleCAO, GC & Sec | 17,421 | — | — | 39,594 | — | |
| Aug 12, 2015 MForm 4 → | Aug 14, 8:29 am EDT | Robert W BreckonDirector | 3,669 | — | — | 8,071 | — | |
| Aug 12, 2015 MForm 4 → | Aug 14, 8:25 am EDT | D. Jamie MacdonaldChief Executive Officer, Director | 116,650 | — | — | 179,207 | — | |
| Jun 30, 2015 AForm 4 → | Jul 2, 8:44 am EDT | Christopher L GaenzleCAO, GC & Sec | 14,581 | — | — | 14,581 | — | |
| Jun 30, 2015 AForm 4 → | Jul 2, 8:41 am EDT | Michael GibertiniPresident Clinical Development | 16,825 | — | — | 16,825 | — | |
| Jun 30, 2015 AForm 4 → | Jul 2, 8:40 am EDT | Gregory S RushExecutive VP and CFO | 16,264 | — | — | 16,264 | — | |
| Jun 30, 2015 AForm 4 → | Jul 2, 8:39 am EDT | Alistair MacdonaldChief Operating Officer | 17,398 | — | — | 17,398 | — | |
| Jun 30, 2015 AForm 4 → | Jul 2, 8:37 am EDT | D. Jamie MacdonaldChief Executive Officer, Director | 50,474 | — | — | 50,474 | — | |
| Jun 5, 2015 AForm 4 → | Jun 9, 9:11 am EDT | Richard N KenderDirector | 3,100 | — | — | 3,100 | — | |
| Jun 5, 2015 AForm 4 → | Jun 9, 8:47 am EDT | David Y NortonDirector | 2,675 | — | — | 2,675 | — | |
| Jun 5, 2015 AForm 4 → | Jun 9, 8:28 am EDT | James T. OgleDirector | 3,401 | — | — | 3,401 | — | |
| Jun 5, 2015 AForm 4 → | Jun 9, 8:26 am EDT | Robert W BreckonDirector | 3,401 | — | — | 3,401 | — | |
| Jun 5, 2015 AForm 4 → | Jun 9, 8:24 am EDT | Charles C Harwood Jr.Director | 3,401 | — | — | 3,401 | — | |
| May 11, 2015 MForm 4 → | May 13, 8:24 am EDT | Gregory S RushExecutive VP and CFO | 2,301 | — | — | 326,478 | — | |
| May 11, 2015 MForm 4 → | May 13, 8:21 am EDT | James T. OgleDirector | 4,191 | — | — | 47,187 | — | |
| May 11, 2015 MForm 4 → | May 13, 8:19 am EDT | Robert W BreckonDirector | 485 | — | — | 11,740 | — | |
| May 7, 2015 MForm 4 → | May 11, 8:17 am EDT | Gregory S RushExecutive VP and CFO | 26,250 | — | — | 328,779 | — | |
| May 7, 2015 MForm 4 → | May 11, 8:12 am EDT | Robert W BreckonDirector | 5,526 | — | — | 12,225 | — | |
| May 7, 2015 MForm 4 → | May 11, 8:07 am EDT | James T. OgleDirector | 47,814 | — | — | 47,962 | — | |
| Feb 3, 2015 AForm 4 → | Feb 4, 4:40 pm EST | David Y NortonDirector | 1,451 | — | — | 1,451 | — |